Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia
ConclusionsFears that COVID-19 would interrupt medicine availability were unfounded in East Java. Public sector patients may have compensated for reduced service access by switching to private pharmacies. Mitigation policies that ignored administrative procedures were not effective.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research
More News: Captopril | Cardiology | Cardiovascular | COVID-19 | Disability | Furosemide | Heart | Indonesia Health | International Medicine & Public Health | Learning | Norvasc | Pandemics | Pharmaceuticals | Simvastatin | Statin Therapy | Universities & Medical Training | Zocor